BIPAP No Backup denied as duplicate or overlapping therapy by Cigna?

Cigna's specific coverage criteria for bipap no backup are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Cigna Denied BiPAP (Without Backup Rate) as Duplicate Therapy

Cigna's duplicate-therapy denial for a BiPAP device without a backup rate means the reviewer determined that another respiratory support device already covered under your plan serves the same clinical function. This most often occurs when a CPAP device is already authorized and active on your account — Cigna's clinical policy may treat BiPAP and CPAP as overlapping for certain diagnoses unless the record clearly establishes that CPAP was tried and was clinically insufficient or that the patient's respiratory profile requires pressure support on both inhalation and exhalation.

## Why This Denial Is Appealable

BiPAP without backup rate (sometimes coded as bilevel positive airway pressure, S-mode) delivers separately adjustable inspiratory and expiratory pressures, which is clinically distinct from fixed-pressure CPAP. If the patient's prescriber determined that CPAP was inadequate — or that the diagnosis and respiratory parameters require bilevel pressure — the clinical distinction is documentable and provides a clear basis for appeal. Cigna's own published coverage policy for positive airway pressure devices typically includes criteria distinguishing when BiPAP is appropriate versus CPAP; meeting those criteria with objective data is the path to overturn.

## Federal Appeal Framework

• Internal appeal (ERISA §503 / ACA): File within the deadline stated on the denial notice (commonly 180 days for ERISA plans).
• External review (ACA §2719): After the final internal denial, request an Independent Review Organization review. The window is approximately four months from the final internal denial.
• Expedited review: Available when standard timelines would pose serious risk to health; requires prescriber certification.

## Concrete Appeal Steps

1. Request Cigna's current published coverage policy for positive airway pressure (PAP) devices — specifically the criteria distinguishing BiPAP from CPAP coverage. 2. Obtain the sleep study or diagnostic report supporting the BiPAP prescription. 3. If CPAP was previously tried, document dates, compliance data, and clinical outcome. 4. Have your prescriber draft a letter explaining the distinct clinical need for bilevel pressure and why CPAP does not meet it. 5. Submit the internal appeal in writing with all supporting records.

## Documentation to Gather

• Diagnostic sleep study: Polysomnography or home sleep apnea test report supporting the bilevel-pressure prescription.
• CPAP trial documentation (if applicable): Dates of CPAP use, objective compliance data (download from device), and clinical notes documenting inadequate response or intolerance.
• Prescriber order and letter: Signed order for BiPAP without backup rate with a medical-necessity letter explaining the clinical distinction from CPAP and the reason bilevel therapy is required for this patient.
• Diagnosis documentation: ICD-10 diagnosis and supporting clinical notes.

## Criteria-Mapping Structure

Obtain Cigna's PAP coverage policy and identify every criterion for BiPAP approval. Create a two-column table: left = policy criterion verbatim; right = chart evidence or prescriber attestation satisfying it. For the duplicate-therapy question specifically, include a column addressing how BiPAP differs clinically from the already-authorized device, with the prescriber's explanation and any objective diagnostic data (e.g., pressure titration results from the sleep study).